The Components of Buyang Huanwu Decoction with UPLC-MS

Abstract

Objective: Buyang-Huanwu Decoction is often used as an adjuvant therapy for ischemic stroke in clinical practice. At the same time, various laboratories have found that it has the potential to treat ischemic heart failure, lower extremity varicose veins, pulmonary hypertension, pulmonary fibrosis, and hyperlipidemia. Previous studies in our laboratory have found that different concentrations of ethanol were used to separate the polar components of Buyang-Huanwu decoction, and the therapeutic effects of each group on pulmonary fibrosis and hyperlipidemia were different. Therefore, we analyzed and explored Buyang Huanwu decoction and its products. Methods: The isolated components were obtained by treatment with absolute ethanol, 30% (v/v), 50% (v/v), 75% (v/v), and 90% (v/v) ethanol, and the components were analyzed by UPLC-MS. Results: The separation method used in our laboratory could well separate the components of Buyang Huanwu Decoction, and simply enrich carbohydrates, organic acids, phenylpropanoid compounds, lipids, nucleotides, and lignans. Conclusions: The products treated with different concentrations of ethanol have different therapeutic potentials. The high content components of 30% ethanol eluate and 50% ethanol eluate have good therapeutic effects on osteoarthritis and bone loss, while the high content components of the precipitate components and 75% eluate are more likely to be related to glucose and lipid metabolism disorders and cardiovascular diseases.

Keywords

Buyang Huanwu decoction UPLC-MS Chinese herbal analysis traditional Chinese medicine flavonoids

Introduction

In recent years, related studies of BHD have shown that it has the potential to treat cerebral ischemia-reperfusion,¹ atherosclerosis,² diabetes,³ hyperlipidemia,⁴ spinal cord injury⁵ and prevent pulmonary fibrosis.⁶ Fu⁷ et al extracted the glycoside in Buyang Huanwu Decoction, and the anti-atherosclerosis ability of the glycoside was basically the same as that of BHD. Several unpublished studies from our laboratory have shown that BHD has different therapeutic effects on pulmonary fibrosis, hypercholesterolemia and nonalcoholic fatty liver disease after being divided into six parts: precipitated components (PC part), distilled water elution components (DW part), 30% ethanol elution components(30% part), 50% ethanol elution components(50% part), 75% ethanol elution components(75% part), 90% ethanol elution components(90% part). Such as the PC part in mixture with the DW part can improve the energy metabolism of erythrocyte membrane,⁸ the 30% and 50% part can be prevention and treatment of pulmonary fibrosis in rats,⁹ 75% parts can reduce the qi deficiency of blood stasis model mice blood viscosity,⁸ the cholesterol content of the hyperlipemia model in mice¹⁰ and the Oleic acid-induced lipid accumulation in hepatocytes.¹¹ It can be seen from the above literature that simple separation of the components of BHD with different concentrations of ethanol can achieve the purpose of treating different diseases. Therefore, we chose to perform compositional analysis of the compounds in each group to identify the components with pharmacological activity in each group and provide theoretical basis for subsequent experiments.

Materials and Methods

Drugs and Reagents

Drugs

The composition of each pair of Buyang Huanwu decoction is as follows: Astragalus membranaceus (Fisch.) Bunge 120 g, Angelica sinensis (Oliv.) Diels 6 g, Paeonia lactiflora Pall 5 g, Ligusticum chuanxiong hort 3 g, Carthamus tinctorius L. 3 g, Prunus persica (L.) Batsch 3 g, Pheretima aspergillum (E. Perrier) 3, which were purchased from the First Hospital of Heilongjiang University of Chinese Medicine. It was identified by associate Professor Wu Junkai of Heilongjiang University of Chinese Medicine as the genuine medicinal material.

Reagent

Distilled water, absolute ethyl alcohol, methanol (Fisher Chemical, HPLC,206408), acetonitrile (Fisher Chemical, HPLC, 205303), Formic acid (CNW, HPLC, 206840), Water (Fisher Chemical, LC-MS,206866), Isopropanol (Merck, HPLC, 01377055/AH323-4), 2-chloro-L-phenylalanine (Adamas-beta, ≥ 98%).

Instrument

Circulating water vacuum pump (Gongyi Yuhua Instrument Co., LTD, SHB-111), rotary evaporator (Shanghai Yarong Biochemical Instrument Factory, RE-52 series), Lyophilizer (Gardner Denver Thomas GmbH), NewClassic MS electronic balance (Mettler Toledo, NewClassic MF MS105DU), freezing Centrifuge (Eppendorf, Centrifuge 5424R), Freezing Centrifuge (Eppendorf, Centrifuge 5430R), temperature controlled ultrasonic cleaner −10L(SBL-10TD, Ningbo Xinzhi Biotechnology Co., LTD), Multi-sample freezing grinder (Wonbio-96c, Shanghai Wanbo Biotechnology Co., LTD), Table rapid centrifugal concentration dryer (Taicang Huami Biochemical Instrument Factory, LNG-T88), nitrogen purging instrument (Shanghai Jingxin Industrial Development Co., LTD, JXDC-20), UHPLC liquid chromatography system (Thermo Scientific, Vanquish Horizon system), mass spectrometer (Thermo Scientific, Q-Exactive HF-X).

Methods

Sample Preparation

Weigh and mix 21 portions of medicine. Soak in 21L distilled water for 30 min and then heat and cook for 90 min. Strain, add 21L of distilled water to the residue and boil for 60 min. Mix filtrate twice and concentrate to 3L. Add ethanol to the solution and stir until the final ethanol concentration is 80%. Let it sit overnight. Supernatant and precipitation are separated the next day. Repeat three times. Name the precipitate “precipitated part”. The supernatant concentrated and passed through the macroporous resin, we get the distilled water elution components (DW part), 30%/50%/75%/90% ethanol elution components(30%/50%/75%/90% part). All products are freeze-dried and stored.

Accurate said samples from 20 ± 5 mg to 2 mL centrifuge tube, add grinding beads 6 mm in diameter and 400 μL extract. The extract was 80% (v/v) aqueous methanol solution containing four internal standards (0.02 mg/mL 2-chloro-L-phenylalanine, etc). The frozen tissue was ground for 6 min (−10 °C, 50 Hz), extracted by low temperature ultrasound for 30 min (5 °C, 40 KHz), left at −20 °C for 30 min, centrifuged (13000 g*15 min, 4 °C), and the supernatant was taken for analysis.

Instrument Condition

Column: ACQUITY UPLC HSS T3 (100 mm × 2.1 mm i.d., 1.8 µm; Waters, Milford, USA); Mobile phase A consisted of 95% water +5% acetonitrile (containing 0.1% formic acid), and mobile phase B consisted of 47.5% acetonitrile +47.5% isopropanol +5% water (containing 0.1% formic acid); The column temperature was 40°C; The injection volume was 3 μL. An electrospray ion source (ESI) was used; The MS signals were collected by positive and negative ion scanning modes (m/z range 70-1050), respectively. The main MS parameters were as follows: sheath gas flow rate was 50 arb; The auxiliary gas flow rate was 13 arb. The heating temperature is 425 °C; Capillary temperature is 325 °C; The electrospray voltage in positive mode was 3500 V, and the electrospray voltage in negative mode was −3500 V. S-Lens voltage is 50; Collision energy is set to 20 eV, 40 eV and 60 eV; The resolution is 60000.

Composition Identification

The raw data were imported into ProgenesisQI (WatersCorporation, Milford,USA) for baseline filtering, peak identification, integration, retention time correction, peak alignment, etc Finally, the data matrix containing retention time, mass-to-charge ratio and peak intensity information was obtained. The MS and MS/MS mass spectrum information were matched with the metabolic database. The MS mass error was set to less than 10 ppm, and the metabolites were identified according to the secondary mass spectrum matching score. In this paper, we will mainly analyze the components with relative abundance greater than 10⁷. Main database is the mainstream public databases such as http://www.hmdb.ca/, https://metlin.scripps.edu/, and the biological medicine company self-built database.

Comparative Analysis

Scipy(Python) (Version1.0.0) was used for sample correlation heatmap analysis. KEGG pathway (Release 2017-05-01) was used for KEGG functional pathway analysis.

Statistic Analysis

All data were processed by ProgenesisQI and summarized using Microsoft Office Excel 2016. The pie charts and bar charts were made using Microsoft Office Word 2016. The weight of the freeze-dried powder, the extraction rate and the retention time of the compound are retained to four decimal places, and the relative abundance of the compound is retained to six decimal places.

Results and Discussion

Conditions of Product Freeze-Drying

In this experiment, the decoction of Buyang Huanwu decoction was separated into six parts. Among them, the precipitated components, 30% ethanol eluting components, 50% ethanol eluting components and 75% ethanol eluting components could be lyophilized into powder, the 90% ethanol eluting components were oil-like after freeze-drying, and the water-eluting components had strong water absorption after freeze-drying. Therefore, the water-elute component was redissolved, so that the final volume was 400 mL. The weights and yields of all groups are shown in Table 1.

Table 1.

Basic Information of Lyophilized Products of Each Component of Buyang Huanwu Decoction.

Group	Freeze-dried state (solid/liquid)	Weight (g)	Yield (%)
PC	solid	128.3508	4.4878
DW	liquid	–	–
30%	solid	28.2147	0.9865
50%	solid	17.2654	0.6037
75%	solid	3.9363	0.1376
90%	liquid	0.6159	0.0215

Software Analysis

Heat map of Sample Correlation

The data analysis of the sample correlation shows the results in Figure 1, with the names of the samples on the right and bottom. Each cell represents the correlation between the two samples, and the different colors represent the relative size of the correlation coefficients between the samples.The darker the color, the more correlated the two samples are. As can be seen from Figure 1, there are strong negative correlations between the water-eluting and 50% sites, between the water-eluting and 75% sites, and between 75% and 90% sites, and between 75% and 90% sites.However, there was no strong correlation between BHD and water elution, between BHD and 30% site, between 50% and 75%, and between 50% and 90%.

Figure 1.

Correlation between samples(BHD: Buyang Huanwu decoction; B-DW: distilled water elution components; B-PC: precipitated components; B30: 30% ethanol elution components; B50: 50% ethanol elution components; B75: 75% ethanol elution components; B90: 90% ethanol elution components).

KEGG Functional Pathways

The product information was compared with the KEGG compound database to obtain the KEGG compound ID number corresponding to the metabolites. According to the KEGG compound ID number, the specific biological pathways involved in a metabolite and the biological function classification information of the metabolite can be obtained, as shown in Figure 2. The analysis results showed that most of the compounds contained in BHD were closely related to metabolism such as amino acid metabolism, lipid metabolism and carbohydrate metabolism. Many components may have a role in different systems of the body, such as the digestive system, the nervous system, the endocrine system, the sensory system, the environmental adaptation system and the immune system. In terms of disease treatment, the obtained data show that some components of BHD are associated with cancer, drug dependence, neurodegenerative diseases, cardiovascular diseases, infectious diseases and endocrine and metabolic diseases. This is also consistent with the reports of in vivo and in vitro pharmacology related to BHD. At the same time, our results also show that a small number of components in BHD are related to environmental information processing, cellular processes, genetic information processing and drug development, suggesting that these aspects can be explored in the future.

Figure 2.

KEGG pathway of Buyang Huanwu decoction.

UPLC-MS Results

HMDB Classification

The HMDB database was used to classify and count the high-content compounds in Buyang Huanwu Decoction and each group, and the results are shown in Figure 3. The content of heterocyclic compounds and benzene derivatives in different components did not have obvious rules, and the other types of compounds were concentrated in some components. Carbohydrates, organic acids and nucleotides were mainly concentrated in the distilled water elution components. Phenylpropanoids, lipids and lignans were mainly concentrated in the 75% and 90% groups, which were less polar. Alkaloids were mainly concentrated in the low polarity 50%, 75% and 90% groups, but because the content was too low, it was not clear whether they had a stable regularity.

Figure 3.

Comparison of the number of various compounds in each component of Buyang Huanwu decoction.

Buyang Huanwu Decoction

According to UPLC-MS and database retrieval and matching, a total of 257 compounds met the requirements and had a large abundance, of which 98 were detected in the negative ion mode and 159 in the positive ion mode. The total ion current diagram is shown in appendix. A total of 33 kinds of carbohydrate, 34 kinds of organic acids, 44 kinds of phenylpropyl and polyketones, 48 kinds of lipids, 9 kinds of nucleosides and nucleotides, 28 kinds of heterocyclic compounds, 14 kinds of benzene derivatives (including 7 kinds of phenols), 3 kinds of lignans, 4 kinds of alkaloids, and 40 kinds of other compounds were detected under the two ion modes. The proportion of various kinds of compounds is shown in Figure 4.

Figure 4.

Types of compounds contained in Buyang Huanwu decoction.

Precipitated Components

A total of 183 compounds that met the requirements and had a large abundance were detected in the precipitate components(PC), of which 41 were detected in the negative ion mode and 142 in the positive ion mode. The total ion current diagram is shown in appendix. A total of 17 kinds of carbohydrate, 38 kinds of organic acids, 20 kinds of phenylpropyl and polyketones, 41 kinds of lipids, 8 kinds of nucleosides and nucleotides, 18 kinds of heterocyclic compounds, 12 kinds of benzene derivatives (including one kind of phenol), 1 kind of alkaloid, and 28 kinds of other compounds were detected in the two ion modes. The proportion of various kinds of compounds is shown in Figure 5.

Figure 5.

Types of compounds contained in the precipitate components.

We searched the compounds in Figure 10 and found that Formononetin, V-PYRRO/NO, Biochanin A, Citrulline and Sebacic acid have some pharmacological activities. Formononetin is a flavonoid compound. As one of the main active ingredients of Astragalus membranaceus, Formononetin has the effects of reducing atherosclerosis,¹² inhibiting liver injury,¹³ protecting neurons,¹⁴ and has antitumor activity.¹⁵ V-PYRRO/NO is a kind of liver specific nitric oxide donor, which can reduce liver injury caused by ischemia-reperfusion,¹⁶ alleviate hepatic steatosis,^17,18 improve glucose tolerance of hepatocytes and optimize the composition of intracellular fatty acids. Biochanin A,¹⁹ derived from Astragalus membranaceus in this prescription, is a isoflavone phytoestrogen with antibacterial, anti-inflammatory, anti-oxidation, anti-cancer, antihypertensive and lipid-lowering activities. Citrulline is an amino acid, which has clinical significance in assisting the diagnosis of rheumatoid arthritis. Studies in various laboratories have found that Citrulline has the potential of anti-inflammatory²⁰ and anti-cancer,²¹ and can also improve renal injury and skeletal muscle atrophy in diabetic mice.²² Sebacic acid is an even, medium-chain dicarboxylic acid. Some studies²³ have shown that oral administration of Sebacic acid can improve hyperglycemia and complications caused by hyperglycemia in diabetic patients. Citrulline and Sebacic acid are unique to the precipitating components of the above compounds.

The main active substances in the precipitated components are less diverse, but there is a high content of Formononetin. Formononetin was also detected in the other groups, indicating that its content was much higher than the adsorption capacity of the macroporous resin. It is speculated that the components in this group have undiscovered potential in the treatment of endocrine diseases (such as type II diabetes mellitus, non-alcoholic fatty liver disease and hyperlipidemia) and cardiovascular diseases (such as ischemia-reperfusion and atherosclerosis).

Distilled Water Elution Components

A total of 219 compounds that met the requirements and had a large abundance were detected in the distilled water elution component(DW), of which 67 were detected in the negative ion mode and 152 in the positive ion mode. The total ion current diagram is shown in appendix. A total of 29 kinds of carbohydrate, 59 kinds of organic acids, 19 kinds of phenylpropyl and polyketones, 33 kinds of lipids, 14 kinds of nucleosides and nucleotides, 26 kinds of heterocyclic compounds, 11 kinds of benzene derivatives (including 4 kinds of phenols), 1 kind of alkaloid, and 27 other compounds were detected in the two ion modes. The proportion of various kinds of compounds is shown in Figure 6.

Figure 6.

Types of compounds contained in the distilled water elution components.

The content of organic acids in the elution group was significantly higher than that in the precipitation group, but the high content components were monosaccharides, disaccharides and amino acids, and there were few kinds of organic acids. Among the top 30 compounds, only V-PYRRO/NO had certain pharmacological activities. The other 99 compounds were only found in the DW group, and 8 of them were reported in pharmacological studies. Difructose anhydride III,²⁴ a cyclic difructose, has been shown to exhibit prebiotic effects, low cariogenicity and cholesterollowering activity. Carglumic acid is a derivative of N-acetylglutamic acid, which is approved by the FDA as a treatment for hyperammonemia. It has also been shown to inhibit the growth of liver and lung cancer cells.²⁵ Beta-Aminoisobutyric acid²⁶ can reduce non-ischemia-reperfusion injury through AMPK/Nrf-2 signaling pathway. D-Pinitol²⁷ is a widely studied natural product, which is known to have insulin sensitive-regulating, anti-inflammatory, anti-oxidative, anti-cancer and hepatoprotective effects. Stachydrine, a bioactive substance widely present in Chinese herbal medicine, has potential for anti-cancer^28,29 and treating diseases of the cardiovascular system and central nervous system.³⁰ Gallic Acid is a kind of polyphenolic organic compound, which is widely found in a variety of plants. In recent years, the research on its pharmacological effects mainly focuses on anti-cancer³¹ Maria³² et al used virgin olive oil to study Hydroxytyrosyl acetate, and found that this compound has the effect of reducing cholesterol in the bile and plasma and improving the antioxidant capacity of the body. It is also speculated that the compound in this study came from the peach kernel, which has a high oil content, similar to the situation in olive oil. Filgotinib³³ is a JAK-1 inhibitor, which can regulate the signaling pathway related to JAK protein, mainly around the anti-inflammatory pharmacological action.

In general, the distilled water-eluting group has good anti-inflammatory, anti-cancer and cardiovascular disease effects, but in our previous study, the water-eluting group has high cytotoxicity and poor treatment effect on the disease model we selected. It is speculated that one of the reasons is that the high content of components in this group does not have too much pharmacological activity. The second reason is that in addition to the compounds with high content only in the DW group discussed above, there are also many toxic substances in this group, which increase the degree of oxidation and inflammation in cells and the body, and then affect the therapeutic effect of the drugs in this group.

30% Ethanol Elution Components

A total of 155 compounds that met the requirements and had a large abundance were detected in the 30% ethanol elution component, of which 63 were detected in the negative ion mode and 92 in the positive ion mode. The total ion current diagram is shown in appendix. A total of 21 kinds of carbohydrate, 26 kinds of organic acids, 19 kinds of phenylpropyl and polyketones, 19 kinds of lipids, 7 kinds of nucleosides and nucleotides, 15 kinds of heterocyclic compounds, 19 kinds of benzene derivatives (including 5 kinds of phenols), 1 kind of lignans, 1 kind of alkaloids, and 27 kinds of other compounds were detected under the two ion modes. The proportion of various compounds is shown in Figure 7.

Figure 7.

Types of compounds contained in the 30 components of 30% ethanol elution components.

In 30% ethanol elution group, Paeoniflorin, Albiflorin, Trifolirhizin, Glycitin and other compounds were among the top 30 substances in the relative abundance. Among them, Paeoniflorin is one of the active substances of red Peony root in this prescription, and it is also the standard for measuring the quality of red peony root in the Chinese Pharmacopoeia. It has anti-inflammatory,^34,35 anti-cancer,³⁶ antidepressant³⁷ and anti-pulmonary fibrosis³⁸ effects. Albiflorin is also one of the active substances of red peony root in this prescription, which has significant anti-inflammatory and oxidative stress relieving effects,³⁹ and can alleviate cerebral ischemia-reperfusion injury⁴⁰ and osteoarthritis injury.⁴¹ Trifolirhizin, a glycoside compound, can inhibit the proliferation and migration of nasopharyngeal carcinoma cells through the PI3 K/Akt signaling pathway,⁴² and induce colon cancer-related cell apoptosis through the AMPK/mTOR signaling pathway.⁴³ Trifolirhizin also has a therapeutic effect on mice with colitis.⁴⁴ Glycitin has therapeutic effects on osteoarthritis,⁴⁵ bone loss⁴⁶and intervertebral disc disease⁴⁷ It can also reduce acute lung injury through NF-κB pathway and MAPKs pathway.⁴⁸ 92 compounds in this group were found to have high content only in 30% ethanol eluate, of which 6 compounds had pharmacological effects. Protocatechuic Acid is a kind of natural phenolic acid, which can prevent non-alcoholic fatty liver disease by regulating intestinal flora.⁴⁹ It can prevent neurodegenerative diseases in rodents and humans.⁵⁰ Amygdalin, the signature compound of peach kernel in this prescription, has antioxidant and anti-cancer activities,⁵¹ and can also improve pulmonary⁵² and liver fibrosis.⁵³ Sakuranetin⁵⁴ is a flavonoid with anti-inflammatory, anti-oxidative, anti-diabetic and neuroprotective properties. Oxypaeoniflorin, a pharmacological component of red Peony root, has antioxidant effect⁵⁵ and can improve acute lung injury⁵⁶ and myocardial ischemia-reperfusion injury.⁵⁷ Coniferaldehyde can reduce the damage of articular cartilage,⁵⁸ alleviate Alzheimer's disease⁵⁹ and reduce cell apoptosis.⁶⁰ Physagulin B is a steroid compound with pharmacological effects such as anti-cancer,⁶¹ inhibition of vascular smooth muscle proliferation and migration,⁶² and alleviation of liver fibrosis.⁶³ Neoisoastilbin can improve acute gouty arthritis through NF-κB pathway. The anti-fibrotic effects of Paeoniflorin and Amygdalin, combined with the anti-inflammatory and anti-oxidative effects of other compounds, are consistent with previous findings in our laboratory.

Taken as a whole, the lyophilized product of 30% ethanol eluent has some potential in the treatment of cartilage and osteoarthritis due to its high content of Albiflorin, Glycitin, Coniferaldehyde, Neoisoastilbin and other bioactive components for osteoarthritis. Meanwhile, other compounds also have the ability to inhibit neurodegenerative diseases. Therefore, the therapeutic effects of this group of compounds on several typical geriatric diseases can be considered.

50% Ethanol Elution Components

A total of 199 compounds that met the requirements and had a large abundance were detected in the 50% ethanol elution component, of which 64 were detected in the negative ion mode and 135 in the positive ion mode. The total ion current diagram is shown in appendix. A total of 14 kinds of carbohydrate, 20 kinds of organic acids, 44 kinds of phenylpropyl and polyketones, 52 kinds of lipids, 18 kinds of heterocyclic compounds, 16 kinds of benzene derivatives (including 2 kinds of phenols), 3 kinds of lignans, 3 kinds of alkaloids, and 29 kinds of other compounds were detected under the two ion modes. The proportion of various compounds is shown in Figure 8.

Figure 8.

Types of compounds contained in the 50% ethanol elution components.

Glycitin, Ononin, Isoformononetin, Calycosin, Curculigoside and other active natural products were found in the top 30 relative abundance substances in the 50% ethanol elution group. Ononin has a wide range of pharmacological activities, which can alleviate colitis,⁶⁴ endoplasmic reticulum stress,⁶⁵ osteoarthritis,⁶⁶ and has anti-cancer potential.⁶⁷ Isoformononetin belongs to flavonoids, which has anti-inflammatory effects,⁶⁸ can prevent osteoblast apoptosis⁶⁹and prevent estrogen deficiency induced osteoporosis.⁷⁰ Calycosin, which is mainly provided by astragalus in this prescription, can mainly treat cardiovascular and cerebrovascular diseases,^71,72 regulate ferroptosis⁷³ and apoptosis,⁷⁴ and has a certain anti-cancer effect.^75,76 Curculigoside can improve osteoporosis,⁷⁷ osteoarthritis⁷⁸ and promote osteoblast differentiation.⁷⁹ A total of 88 compounds in this group were found to have high content only in 50% ethanol eluent, and 5 of these compounds had pharmacological effects. Ginkgolide A⁸⁰ has been shown to have anti-inflammatory, anti-cancer, anti-atherosclerotic and liver-protective effects. Hesperidin can fight pulmonary fibrosis,⁸¹ protect the nervous system,⁸² and fight osteoporosis.⁸³ Xanthotoxol⁸⁴ inhibits neuroinflammatory response and alleviates secondary brain injury after intracerebral hemorrhage. Liquiritigenin has hepatoprotective⁸⁵ and anti-cancer⁸⁶ effects. Cirsimarin⁸⁷ is a flavonoid glucoside that is effective in fighting fat accumulation.

The lyophilized product of the 50% ethanol eluent, like the 30% group, has some potential for treating cartilage and osteoarthritis. Different from the 30% ethanol eluent, which focuses on anti-inflammatory ability, the 50% ethanol eluent is more inclined to promote osteoblast differentiation by mimicking estrogen, thereby reducing bone loss and treating diseases.

75% Ethanol Elution Components

A total of 270 compounds that met the requirements and had a large abundance were detected in the 75% ethanol elution component, of which 96 were detected in the negative ion mode and 174 in the positive ion mode. The total ion current diagram is shown in appendix. A total of 19 kinds of carbohydrate, 15 kinds of organic acids, 56 kinds of phenylpropyl and polyketones, 78 kinds of lipids, 1 kind of nucleoside or nucleotide, 19 kinds of heterocyclic compounds, 25 kinds of benzene derivatives (including 7 kinds of phenols), 11 kinds of lignans, 3 kinds of alkaloids and 43 kinds of other compounds were detected in the two ion modes. The proportion of various kinds of compounds is shown in Figure 9.

Figure 9.

Types of compounds contained in 75% ethanol elution components.

There were Calycosin, Biochanin A, Ononin, Acacetin and other bioactive components in the top 30 relative abundance substances in the 75% ethanol elution components, among which only Acacetin did not have high relative content in the other groups. Acacetin can prevent cardiovascular diseases,⁸⁸ prevent liver lipid accumulation induced by high-fat diet,⁸⁹ and also has a certain inhibitory effect on gastric cancer.⁹⁰ Another 93 compounds were only found in 75% ethanol group, many of which have been reported by pharmacological studies. For example, afzelechin⁹¹ can alleviate lung injury, traumatic acid⁹² can inhibit lipid accumulation in adipocytes, 3-Hydroxyphenylacetic acid⁹³ can alleviate aging-related spermatogenic dysfunction, swertiajaponin⁹⁴ can inhibit skin pigmentation, and so on. Cirsiliol⁹⁵and Gingerol⁹⁶ have the potential to treat cancer, and Deltonin can induce apoptosis of cancer cells⁹⁷ and improve the sensitivity of cells to chemotherapeutic drugs.⁹⁸ Astragaloside III can enhance the anti-tumor response of NK cells⁹⁹ and activate TACE/ ADAM38-dependent anti-inflammatory effect in endothelial cells.¹⁰⁰ Astragaloside IV¹⁰¹ is an important bioactive substance of Astragaloside in this prescription, and it is stipulated in the Chinese Pharmacopoeia that the quality of astragaloside should be measured as a standard. Astragaloside IV is involved in multiple pathways and plays a role in neuroprotection, anti-diabetes, liver protection and anti-cancer. Ferutinin is a phytoestrogen with antioxidant and anti-cancer pharmacological effects.¹⁰²

Acacetin and Astragaloside IV were able to protect the liver by reducing lipid accumulation in the liver, which was consistent with previous findings from our laboratory that 75% ethanol eluate reduced cholesterol content in hyperlipidemic mice and intracellular triglyceride content in L02 cells under high oleic acid condition. The active components of 75% ethanol eluate are mainly flavonoids, glycosides and steroids. Pharmacological studies on these components are mainly anti-inflammatory and anti-cancer, followed by the treatment of lipid accumulation in liver and adipocytes. For later research, the next experiment can be carried out from the direction of anti-inflammatory and anti-cancer.

90% Ethanol Elution Components

A total of 256 compounds that met the requirements and had a large abundance were detected in the 90% ethanol elution component, of which 94 were detected in the negative ion mode and 162 in the positive ion mode. The total ion current diagram is shown in appendix. A total of 18 kinds of carbohydrate, 23 kinds of organic acids, 52 kinds of phenylpropyl and polyketones, 83 kinds of lipids, 1 kind of nucleoside or nucleotide, 19 kinds of heterocyclic compounds, 18 kinds of benzene derivatives (including 3 kinds of phenols), 4 kinds of lignans, 3 kinds of alkaloids, and 35 kinds of other compounds were detected under the two ion modes. The proportion of various compounds is shown in Figure 10.

Figure 10.

Types of compounds contained in 90% ethanol elution components.

Isoformononetin, Calycosin, Acacetin, Tectochrysin and other bioactive substances were found in the top 30 substances in the elution components of 90% ethanol eluate. Tectochrysin can directly induce the anti-inflammatory effect of macrophages¹⁰³ and alleviate learning and memory impairment.¹⁰⁴ 3-butylidene-4,5-dihydrophthalide, a volatile extract mainly from Angelica sinensis and Ligusticum Chuanxiongxi, has antioxidant activity and can improve retinal dysfunction in diabetic rats.¹⁰⁵ Another 78 compounds were only found at high levels in 90% ethanol eluate, several of which have been reported in pharmacological studies. Isoliquiritigenin, for example, has anti-inflammatory¹⁰⁶ and anti-viral¹⁰⁷ effects and can alleviate liver and kidney injury^108,109 and fibrosis through mediating ferroptosis. Ginsenoside Ro can inhibit the growth of melanoma¹¹⁰ and reduce lipid accumulation and insulin resistance in high-fat diet mice.¹¹¹ Soyasapogenol B has anti-cancer activity,^112,113 and recent studies have shown its potential to treat neurodegenerative diseases.¹¹⁴

The active ingredient in the 90% ethanol eluent does not have obvious application in the known pharmacological literature. In addition, the freeze-dried product of this part is oil-like and poorly water-soluble, and its bioavailability needs to be further optimized.

Conclusion

The composition of the six effective fractions was different, which may be due to water extraction and alcohol precipitation and column chromatography gradient elution. The composition of the six effective fractions was different, which may be due to water extraction and alcohol precipitation and column chromatography gradient elution. Water extraction and alcohol precipitation is a common means of separating alcohol-soluble and alcohol-insoluble components,¹¹⁵ which will convert large molecules such as polysaccharides and proteins and strongly polar small molecules such as inorganic salts into precipitation, while the alcohol-soluble components continue to remain in the supernatant. Column chromatography is also a common means of separating complex components.¹¹⁶ Components of different polarity and molecular weight can be separated by the difference in the polarity of the mobile phase. The AB-8 macroporous resin we used is one of the commonly used fixed phases of this method.

The use of different concentrations of ethanol instead of different organic solvents (such as ethyl acetate, petroleum ether, etc) is a reference basis for the separation of the solution after water extraction and alcohol precipitation.¹¹⁷ The difference from the reference literature is that we did not further separate the components of different parts, because the same batch of drugs needs to be tested in vivo and in vitro pharmacodynamics. Although the highest point of the concentration gradient set in the paper is not anhydrous ethanol, our experiment has tried to do this. After the early elution, the samples obtained from the elution of anhydrous ethanol are not much left after rotation evaporation. This experiment is expected to analyze the active components of different parts, hoping that it can guide the follow-up pharmacological experiments of our laboratory, so no further study was carried out on the parts with too low yield.

There are also some common components in the six groups of effective parts. The reasons for the existence of these components may be as follows: 1. Although the separation method of the mixture of water extraction and alcohol precipitation is simple, the rapid precipitation may wrap the compounds that should exist in the supernatant, forming a “co-precipitation".¹¹⁸ 2. From 30% ethanol to 90% ethanol is a mixture of ethanol and water, so components with similar solubility to water and ethanol are likely to be detected.

In general, the six effective parts extracted by our method can be regarded as different and related drugs, and the difference of compounds in each part caused the difference between the results of each group in our preliminary experiment.^8‐11 From the results of this analysis, our laboratory may conduct further research on the mechanism of the precipitated components and 75% parts in the treatment of glucose and lipid metabolism disorders and cardiovascular diseases. It is also considered to use these components in experiments on osteoarthritis, bone loss model animals and cells to further investigate differences in the treatment of various parts.

However, the manuscript has some limitations: the results of our analysis are limited to the medicinal materials purchased at this time. For the herbs with the same name but different species (such as Astragalus mongolicus and Astragalus membranaceus) that may exist in the prescription, different results may also be obtained by using the method in this manuscript.

Supplemental Material

sj-docx-1-npx-10.1177_1934578X241275820 - Supplemental material for The Components of Buyang Huanwu Decoction with UPLC-MS

Supplemental material, sj-docx-1-npx-10.1177_1934578X241275820 for The Components of Buyang Huanwu Decoction with UPLC-MS by Shijian Fang, Yuxue Ma, Shuaihu Yang, Ruihong Yang, Xingtong Chen, Jinbiao Yang, Yunyue Zhou, Hongbin Xiao, Yukun Zhang and Wenying Niu in Natural Product Communications

Footnotes

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Natural Science Foundation of China (grant number 82074326, 82274405).

Ethical Approval

Ethical approval is not applicable for this article.

ORCID iD

Shijian Fang

Statement of Human and Animal Rights

This article does not contain any studies with humans or animal subjects.

Statement of Informed Consent

There are no human subjects in this article and informed consent is not applicable.

Supplemental Material

There are no human subjects in this article and informed consent is not applicable.

References

She

Shao

Jiao

, et al. Glycosides of Buyang Huanwu decoction inhibits pyroptosis associated with cerebral ischemia-reperfusion through Nrf2-mediated antioxidant signaling pathway both in vivo and in vitro. Phytomedicine. 2023 Nov;120:155001. doi: https://doi.org/10.1016/j.phymed.2023.155001. Epub 2023 Jul 30. PMID: 37619321.

Tong

Leng

Wang

, et al. Buyang Huanwu decoction inhibits diabetes-accelerated atherosclerosis via reduction of AMPK-Drp1-mitochondrial fission axis. J Ethnopharmacol. 2023 Aug 10;312:116432. doi: https://doi.org/10.1016/j.jep.2023.116432. Epub 2023 Mar 30. PMID: 37003404.

Meizhen

Xiaohui

Yiting

, et al. Efficacy and safety of Buyang Huanwu decoction for diabetic peripheral neuropathy: a systematic review and metaanalysis. J Tradit Chin Med. 2023 Oct;43(5):841-850. doi: https://doi.org/10.19852/j.cnki.jtcm.20230802.002. PMID: 37679971; PMCID: PMC10465838.

Man

Geng

Zhao

, et al. Xiaoshuan oral liquid pharmacological action on experimental big white rats with hyperlipidemia. Heilongjiang Medicine. 2001;01(01):18‐19.

Song

Yang

, et al. Buyang Huanwu decoction promotes the neurological recovery of traumatic spinal cord injury via inhibiting apoptosis, inflammation, and oxidative stress. Immun Inflamm Dis. 2023 Jul;11(7):e933. doi: https://doi.org/10.1002/iid3.933. PMID: 37506135; PMCID: PMC10336660.

Feng

Dai

Zhang

, et al. Buyang Huanwu decoction alleviates blood stasis, platelet activation, and inflammation and regulates the HMGB1/NF-κB pathway in rats with pulmonary fibrosis. J Ethnopharmacol. 2024 Jan 30;319(Pt 1):117088. doi: https://doi.org/10.1016/j.jep.2023.117088. Epub 2023 Aug 29. PMID: 37652195.

Sun

Long

, et al. Glycosides from Buyang Huanwu decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway. Phytomedicine. 2022 Oct;105:154385. doi: https://doi.org/10.1016/j.phymed.2022.154385. Epub 2022 Aug 8. PMID: 35987015.

. Study on hemorheology and erythrocyte membrane components of different chemical parts of Buyang Huanwu Decoction in rats with qi deficiency and blood stasis model. Heilongjiang University of Chinese Medicine; 2021.

Ren

. Study on the improvement effect and mechanism of different components of Buyang Huanwu Decoction on pulmonary fibrosis in rats. Heilongjiang University of Chinese Medicine; 2023.

10.

Yang

. Effects of Different Components of Buyang Huanwu Tang on the PPARγ/LXRα/ABCA1 Pathway in Hyperlipidaemic Model Mice. Heilongjiang University of Chinese Medicine; 2024.

11.

Fang

. To investigate the effect of Buyang Huanwu Decoction and its active parts on hepatic steatosis based on AMPK related targets. Heilongjiang University of Chinese Medicine; 2024.

12.

Xia

Yang

, et al. Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in ApoE^−/− mice. Theranostics. 2020 Jan 1;10(3):1090‐1106. doi: https://doi.org/10.7150/thno.38115. PMID: 31938053; PMCID: PMC6956811.

13.

Zhang

Sun

, et al. Formononetin inhibits hepatic I/R-induced injury through regulating PHB2/PINK1/Parkin pathway. Oxid Med Cell Longev. 2022 Dec 2;2022:6481192. doi: https://doi.org/10.1155/2022/6481192. PMID: 36506934; PMCID: PMC9734001.

14.

Wang

. Formononetin: a pathway to protect neurons. Front Integr Neurosci. 2022 Jul 13;16(9):08378. Doi: https://doi.org/10.3389 / fnint. 2022.908378. PMID: 35910340; PMCID: PMC9326316.

15.

Tay

Tan

Chan

, et al. Formononetin: a review of its anticancer potentials and mechanisms. Front Pharmacol. 2019 Jul 26;10:820. Doi: https://doi.org/10.3389 / fphar. 2019.00820. PMID: 31402861; PMCID: PMC6676344.

16.

Kus

Jiasiński

Skorka

, et al. Short-term treatment with hepatoselective NO donor V-PYRRO/NO improves blood flow in hepatic microcirculation in liver steatosis in mice. Pharmacol Rep. 2018 Jun;70(3):463‐469. doi: https://doi.org/10.1016/j.pharep.2017.11.019. Epub 2017 Dec 2. PMID: 29631249.

17.

Maslak

Zabielski

Kochan

, et al. The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet. Biochem Pharmacol. 2015 Feb 1;93(3):389‐400. doi: https://doi.org/10.1016/j.bcp.2014.12.004. Epub 2014 Dec 19. PMID: 25534988.

18.

Kus

Walczak

Maslak

, et al. Hepatoselective nitric oxide (NO) donors, V-PYRRO/NO and V-PROLI/NO, in nonalcoholic fatty liver disease: a comparison of antisteatotic effects with the biotransformation and pharmacokinetics. Drug Metab Dispos. 2015 Jul;43(7):1028‐1036. doi: https://doi.org/10.1124/dmd.115.063388. Epub 2015 Apr 13.PMID: 25870102.

19.

Yan-jun

Nan

Jia-qi

, et al. Research progress on the biological function of chickpea A [J]. Chinese Journal of Animal Nutrition. 2022;4:2177‐2185.

20.

Ciesielski

Biesiekierska

Panthu

, et al. Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives. Cell Mol Life Sci. 2022 Jan 25;79(2):94. doi: https://doi.org/10.1007/s00018-022-04126-3. PMID: 35079870; PMCID: PMC8788905.

21.

Yuzhalin

. Citrullination in cancer. Cancer Res. 2019 Apr 1;79(7):1274‐1284. doi: https://doi.org/10.1158/0008-5472.CAN-18-2797. Epub 2019 Mar 20.PMID: 30894374.

22.

Taiyue

Xiaoyi

Xinyu

, et al. Effects of citrulline on renal injury and skeletal muscle atrophy in diabetic nephropathy mice [J]. Acta Nutrimenta Sinica. 2023;45(05):441-447. doi: https://doi.org/10.13325/j.cnki.acta.nutr.sin.2023.05.006

23.

Mingrone

Castagneto-Gissey

Mace

. Use of dicarboxylic acids in type 2 diabetes. Br J Clin Pharmacol. 2013 Mar;75(3):671‐676. doi: https://doi.org/10.1111/j.1365-2125.2012.04177.x. PMID: 22242741; PMCID: PMC3575934.

24.

Zhu

Zhang

, et al. Recent advances on biological production of difructose dianhydride III. Appl Microbiol Biotechnol. 2018 Apr;102(7):3007‐3015. doi: https://doi.org/10.1007/ s00253-018-8834-7. Epub 2018 Feb 23.PMID: 29476401.

25.

Chen

Yamaguchi

Hung

. Carglumic acid promotes apoptosis and suppresses cancer cell proliferation in vitro and in vivo. Am J Cancer Res. 2015 Nov 15;5(12):3560‐3569. PMID: 26885446; PMCID: PMC4731631.

26.

Zhang

Guo

, et al. β-aminoisobutyrics acid, a metabolite of BCAA, activates the AMPK/Nrf-2 pathway to prevent ferroptosis and ameliorates lung ischemia-reperfusion injury. Mol Med. 2023 Dec 4;29(1):164. doi: https://doi.org/10.1186/s10020-023-00729-z. PMID: 38049750; PMCID: PMC10696792.

27.

Azab

. D-Pinitol-Active natural product from carob with notable insulin regulation. Nutrients. 2022 Mar 30;14(7):1453. doi: https://doi.org/10.3390/ nu14071453. PMID: 35406064; PMCID: PMC9003036.

28.

Chen

Yan

. Stachydrine inhibits TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells through the TGF-β/Smad and PI3 K/Akt/mTOR signaling pathways. Anticancer Drugs. 2021 Sep 1;32(8):786‐792. doi: https://doi.org/10.1097/CAD.0000000000001066. PMID: 33675608.

29.

Bao

Liu

Huang

, et al. Stachydrine hydrochloride inhibits hepatocellular carcinoma progression via LIF/AMPK axis. Phytomedicine. 2022 Jun;100:154066. Doi: https://doi.org/10.1016 / j. hymed. 2022.154066. Epub 2022 Mar 21. PMID: 35366490.

30.

Liao

Tang

, et al. Stachydrine, a potential drug for the treatment of cardiovascular system and central nervous system diseases. Biomed Pharmacother. 2023 May;161:114489. Doi: https://doi.org/10.1016 / j.b iopha. 2023.114489. Epub 2023 Mar 20. PMID: 36940619.

31.

Hassani

Ghanbari

Lotfi

, et al. How gallic acid regulates molecular signaling: role in cancer drug resistance. Med Oncol. 2023 Sep 27;40(11):308. doi: https://doi.org/10.1007/ s12032-023-02178-4. PMID: 37755616.

32.

Tabernero

Sarria

Largo

, et al. Comparative evaluation of the metabolic effects of hydroxytyrosol and its lipophilic derivatives (hydroxytyrosyl acetate and ethyl hydroxytyrosyl ether) in hypercholesterolemic rats. Food Funct. 2014 Jul 25;5(7):1556‐1563. doi: https://doi.org/10.1039/ c3fo60677e. PMID: 24855654.

33.

Namour

Anderson

Nelson

Tasset

. Filgotinib: a clinical pharmacology review. Clin Pharmacokinet. 2022 Jun;61(6):819‐832. doi: https://doi.org/10.1007/ s40262-022-01129-y. Epub 2022 May 31. PMID: 35637376; PMCID: PMC9249714.

34.

Zhang

Wei

. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020 Mar;207:107452. Doi: https://doi.org/10.1016 / j. harmthera. 2019.107452. 2019 Dec 10. Epub PMID: 31836457.

35.

Wang

You

, et al. Paeoniflorin prevents aberrant proliferation and differentiation of intestinal stem cells by controlling C1q release from macrophages in chronic colitis. Pharmacol Res. 2022 Aug;182:106309. Doi: https://doi.org/10.1016 / j. HRS. 2022.106309. Epub 2022 Jun 16. PMID: 35716915.

36.

Xiang

Zhang

Wei

, et al. Paeoniflorin: a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities. J Pharm Pharmacol. 2020 Apr;72(4):483‐495. doi: https://doi.org/10.1111/ jphp.13204. Epub 2019 Dec 19.PMID: 31858611.

37.

Wang

Feng

Wang

, et al. Paeoniflorin: a neuroprotective monoterpenoid glycoside with promising anti-depressive properties. Phytomedicine. 2021 Sep;90:153669. Doi: https://doi.org/10.1016 / j. hymed. 2021.153669. Epub 2021 Jul 22. PMID: 34334273.

38.

Dou

Zhao

, et al. Paeoniflorin mediated TGF-βmediated epithelial-mesenchymal transition in pulmonary fibrosis through a smad-dependent pathway. Acta Pharmacol Sin. 2016 Jun;37(6):794‐804. doi: https://doi.org/10.1038/ aps.2016.36. Epub 2016 May 2. PMID: 27133302; PMCID: PMC4954768.

39.

Wang

Tan

, et al. Albiflorin alleviates DSS-induced ulcerative colitis in mice by reducing inflammation and oxidative stress. Iran J Basic Med Sci. 2023 Jan;26(1):48‐56. Doi: https://doi.org/10.22038 / IJBMS 2022.66678.14624. PMID: 36594064; PMCID: PMC9790056.

40.

Zhu

Xiong

, et al. Albiflorin relieves cerebral ischemia-reperfusion injury by activating Nrf2/HO-1 pathway. Histol Histopathol. 2023 Feb;38(2):233‐245. doi: https://doi.org/10.14670/ HH-18-518. Epub 2022 Sep 19. PMID: 36121178.

41.

Zhou

Liu

, et al. Albiflorin alleviation efficacy in osteoarthritis injury using in-vivo and in-vitro models. J Pharm Pharmacol. 2023 Oct 5;75(10):1332‐1343. doi: https://doi.org/10.1093/jpp/rgad064.PMID: 37403239

42.

Jiang

Yin

, et al. Trifolirhizin inhibits proliferation, migration and invasion in nasopharyngeal carcinoma cells via PI3 K/akt signaling pathway suppression. Biochem Biophys Res Commun. 2023 Jul 30;667:111‐119. Doi: https://doi.org/10.1016 / j.b BRC. 2023.05.030. Epub 2023 May 10. PMID: 37216826.

43.

Sun

Tao

Zhang

, et al. Trifolirhizin induces autophagy-dependent apoptosis in colon cancer via AMPK/mTOR signaling. Signal Transduct Target Ther. 2020 Aug 27;5(1):174. doi: https://doi.org/10.1038/ s41392-020-00281-w. PMID: 32855395; PMCID: PMC7452898.

44.

Zhang

Wang

. Trifolirhizin regulates the balance of Th17/Treg cells and inflammation in the ulcerative colitis mice through inhibiting the TXNIP-mediated activation of NLRP3 inflammasome. Clin Exp Pharmacol Physiol. 2022 Aug;49(8):787‐796. doi: https://doi.org/10.1111/1440-1681.13654. Epub 2022 Jun 20.PMID: 35575951.

45.

Wang

Yang

Zhang

, et al. Glycitin suppresses cartilage destruction of osteoarthritis in mice. Inflammation. 2020 Aug;43(4):1312‐1322. doi: https://doi.org/10.1007/ s10753-020-01210-3. PMID: 32222871.

46.

Uesugi

Toda

Tsuji

Ishida

. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin. Biol Pharm Bull. 2001 Apr;24(4):368‐372. doi: https://doi.org/10.1248/ bpb.24.368. PMID: 11305597.

47.

Zhao

Cheng

, et al. The antioxidant Glycitin protects against intervertebral disc degeneration through antagonizing inflammation and oxidative stress in nucleus pulposus cells. Aging (Albany NY). 2023 Nov 28;15(23):13693‐13709. doi: https://doi.org/10.18632/ aging.205251. Epub 2023 Nov 28.PMID: 38019477; PMCID: PMC10756108.

48.

Chen

Guo

Jiang

, et al. Glycitin protects ates lipopolysactic-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice. Int Immunopharmacol. 2019 Oct;75:105749. Doi: https://doi.org/10.1016 / j.i ntimp. 2019.105749. Epub 2019 Jul 12. PMID: 31306981.

49.

Tan

Gong

, et al. Protection against metabolic associated fatty liver disease by protocatechuic acid. Gut Microbes. 2023 Jan-Dec;15(1):2238959. Doi: https://doi.org/10.1080/19490976.2023.2238959. PMID: 37505920; PMCID: PMC10392757.

50.

Krzysztoforska

Mirowska-Guzel

Widy-Tyszkiewicz

. Pharmacological effects of protocatechuic acid and its therapeutic potential in neurodegenerative diseases: review on the basis of in vitro and in vivo studies in rodents and humans. Nutr Neurosci. 2019 Feb;22(2):72‐82. The doi: 10.1080/1028415 x. 2017.1354543. Epub 2017 Jul 26. PMID: 28745142.

51.

Barakat

Aljutaily

Almujaydil

, et al. Amygdalin: a review on its characteristics, antioxidant potential, gastrointestinal Microbiota intervention, anticancer therapeutic and mechanisms, toxicity, and encapsulation. Biomolecules. 2022 Oct 19;12(10):1514. doi: https://doi.org/10.3390/ biom12101514. PMID: 36291723; PMCID: PMC9599719.

52.

Jiao

Tang

. Amygdalin epimers exert discrepant anti-pulmonary fibrosis activity via inhibiting TGF-β1/Smad2/3 pathway. Pulm Pharmacol Ther. 2023 Aug;81:102230. Doi: https://doi.org/10.1016 / j. while upt. 2023.102230. Epub 2023 Jun 25. PMID: 37364767.

53.

Xiao

, et al. Amygdalin ameliorates liver fibrosis through inhibiting activation of TGF-β/Smad signaling. Chin J Integr Med. 2023 Apr;29(4):316‐324. doi: https://doi.org/10.1007/ s11655-021-3304-y. Epub 2021 Nov 24.PMID: 34816365.

54.

Junaid

Basak

Akter

, et al. Sakuranetin and its therapeutic potentials - a comprehensive review. Z Naturforsch C J Biosci. 2022 Jul 13;78(1-2):27‐48. doi: https://doi.org/10.1515/ znc-2022-0024. PMID: 35844107.

55.

Yoshikawa

Uchida

Kawaguchi

, et al. Galloyl-oxypaeoniflorin, suffruticosides A, B, C, and D, five new antioxidative glycosides, and suffruticoside E, A paeonol glycoside, from Chinese moutan cortex. Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2248‐2250. doi: https://doi.org/10.1248/ cpb.40.2248. PMID: 1423794.

56.

Guohua

Tieyuan

Rui

Juan

. Oxypaeoniflorin prevents acute lung injury induced by lipopolysaccharide through the PTEN/AKT pathway in a Sirt1-dependent manner. Oxid Med Cell Longev. 2021 Aug 4;2021(1):6878026. doi: https://doi.org/10.1155/2021/6878026. PMID: 34394832; PMCID: PMC8357472.

57.

Wang

. Oxypaeoniflorin improves myocardial ischemia/reperfusion injury by activating the Sirt1/Foxo1 signaling pathway. Acta Biochim Pol. 2020 Jun 18;67(2):239‐245. doi: https://doi.org/10.18388/abp.2020_5206. PMID: 32550708.

58.

Cai

Wang

Chen

, et al. Coniferaldehyde prevents articular cartilage destruction in a murine model via Nrf2/HO 1 pathway. Mol Med Rep. 2021 Mar;23(3):224. doi: https://doi.org/10.3892/mmr.2021.11863. Epub 2021 Jan 26.PMID: 33495836; PMCID: PMC7851827.

59.

Dong

Stewart

Bai

, et al. Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets. Theranostics. 2020 Jan 1;10(1):179‐200. doi: https://doi.org/10.7150/thno.36722. PMID: 31903114; PMCID: PMC6929631.

60.

Kim

Heo

Kim

, et al. Coniferaldehyde inhibits LPS-induced apoptosis through the PKCα / βII /Nrf-2/HO-1 dependent pathway in RAW264.7 macrophage cells. Environ Toxicol Pharmacol. 2016 Dec;101:5‐93. doi: https://doi.org/10.1016/j.etap.2016.10.016. Epub 2016 Oct 17. PMID: 27770660.

61.

Fang

Chen

Yang

, et al. Physalin B inhibits cell proliferation and induces apoptosis in undifferentiated human gastric cancer HGC-27 cells. Asia Pac J Clin Oncol. 2022 Jun;18(3):224‐231. doi: https://doi.org/10.1111/ajco.13593. Epub 2021 Jun 23.PMID: 34161670.

62.

Qiu

Liu

, et al. Physalin B inhibits PDGF-BB-induced VSMC proliferation, migration and phenotypic transformation by activating the Nrf2 pathway. Food Funct. 2021 Nov 1;12(21):10950‐10966. doi: https://doi.org/10.1039/d1fo01926k. PMID: 34647944.

63.

Zhu

, et al. Physalin B attenuates liver fibrosis via suppressing LAP2 alpha HDAC1 - mediated deacetylation of the transcription factor GLI1 and hepatic stellate cell activation. Br J Pharmacol. 2021 Sep;178(17):3428‐3447. doi: https://doi.org/10.1111/bph.15490. Epub 2021 May 21. PMID: 33864382.

64.

Liang

, et al. Ononin alleviates DSS-induced colitis through inhibiting NLRP3 inflammasome via triggering mitophagy. Immun Inflamm Dis. 2023 Feb;11(2):e776. doi: https://doi.org/10.1002/iid3.776. PMID: 36840499; PMCID: PMC9910166.

65.

Zhang

Weng

Sun

, et al. Ononin alleviates endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity by activating SIRT3. Toxicol Appl Pharmacol. 2022 Oct 1;452:116179. Doi: https://doi.org/10.1016/j.t.aap.2022.116179. Epub 2022 Jul 29. PMID: 35914558.

66.

Zhao

Liao

, et al. Ononin ameliorates inflammation and cartilage degradation in rat chondrocytes with IL-1β-induced osteoarthritis by downregulating the MAPK and NF-κB pathways. BMC Complement Med Ther. 2022 Jan 27;22(1):25. doi: https://doi.org/10.1186/s12906-022-03504-5. PMID: 35086536; PMCID: PMC8793192.

67.

Gong

Ganesan

Xiong

Zheng

. Antitumor effects of ononin by modulation of apoptosis in non-small-cell lung cancer through inhibiting PI3 K/Akt/mTOR pathway. Oxid Med Cell Longev. 2022 Dec 27;2022(1):5122448. doi: https://doi.org/10.1155/2022/5122448. PMID: 36605098; PMCID: PMC9810408.

68.

Chaturvedi

Tiwari

Gangadhar

, et al. Isoformononetin, a dietary isoflavone protects against streptozotocin induced rat model of neuroinflammation through inhibition of NLRP3/ASC/IL-1 axis activation. Life Sci. 2021 Dec 1;286:119989. Doi: https://doi.org/10.1016/j.lfs.2021.119989. Epub 2021 Sep 28. PMID: 34597609.

69.

Srivastava

Tyagi

Khan

, et al. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis. Phytomedicine. 2013 Apr 15;20(6):470‐480. The doi: 10.1016 / j. hymed. 2012.12.021. Epub 2013 Feb 8. PMID: 23395215.

70.

Mansoori

Tyagi

Shukla

, et al. Methoxyisoflavones formononetin and isoformononetin inhibit the differentiation of Th17 cells and B-cell lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions. Menopause. 2016 May;23(5):565‐576. The doi: 10.1097 / GME. 0000000000000646. PMID: 27070807.

71.

Liu

Zhao

Yan

, et al. Calycosin decreases cerebral ischemia/reperfusion injury by suppressing ACSL4-dependent ferroptosis. Arch Biochem Biophys. 2023 Jan 15;734:109488. Doi: https://doi.org/10.1016/j.a bb.2022.109488. 2022 Dec 11. Epub PMID: 36516890.

72.

Huang

Yang

Wan

. Calycosin alleviates cerebral ischemia/reperfusion injury by repressing autophagy via STAT3/FOXO3a signaling pathway. Phytomedicine. 2023 Jul;115:154845. Doi: https://doi.org/10.1016/j.hymed.2023.154845. Epub 28 Apr 2023. PMID: 37148714.

73.

Huang

Shen

Wang

, et al. Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis. Pharm Biol. 2022 Dec;60(1):990‐996.

74.

Shi

Jie

, et al. Calycosin mitigates chondrocyte inflammation and apoptosis by inhibiting the PI3 K/AKT and NF-κB pathways. J Ethnopharmacol. 2022 Oct 28;297:115536.

75.

Chen

, et al. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3 K/AKT signaling pathway. Phytomedicine. 2023 Sep;118:154924.

76.

Hsu

, et al. Calycosin inhibits gemcitabine-resistant lung cancer cells proliferation through modulation of the LDOC1/GNL3L/NFκB. Chin J Physiol. 2023 Jul-Aug;66(4):189‐199.

77.

Wang

Cui

Guo

. Curculigoside attenuates osteoporosis through regulating DNMT1 mediated osteoblast activity. In Vitro Cell Dev Biol Anim. 2023 Oct;59(9):649‐657.

78.

Wang

Liu

Zhou

, et al. Curculigoside inhibits osteoarthritis via the regulation of NLRP3 pathway. Eur J Histochem. 2023 Dec 13;67(4):3896.

79.

You

. Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis. J Orthop Surg Res. 2021 Apr 26;16(1):279.

80.

Sarkar

Quispe

Jamaddar

, et al. Therapeutic promises of ginkgolide A: a literature-based review. Biomed Pharmacother. 2020 Dec;132:110908.

81.

Han

Gong

Wei

, et al. Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis. Phytomedicine. 2023 Apr;112:154680.

82.

Huang

Tan

, et al. The benefits of hesperidin in central nervous system disorders, based on the neuroprotective effect. Biomed Pharmacother. 2023 Mar;159:114222.

83.

Zhang

Jiang

, et al. Hesperidin anti-osteoporosis by regulating estrogen signaling pathways. Molecules. 2023 Oct 9;28(19):6987.

84.

Zhu

Sun

, et al. Xanthotoxol alleviates secondary brain injury after intracerebral hemorrhage by inhibiting microglia-mediated neuroinflammation and oxidative stress. Neurochirurgie. 2023 May;69(3):101426.

85.

Zhang

Xue

Zheng

, et al. Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy. Biomed Pharmacother. 2021 Nov;143:112167.

86.

Liang

Zhang

Gao

, et al. Liquiritigenin decreases tumorigenesis by inhibiting DNMT activity and increasing BRCA1 transcriptional activity in triple-negative breast cancer. Exp Biol Med (Maywood). 2021 Feb;246(4):459‐466.

87.

Zarrouki

Pillon

Kalbacher

, et al. Cirsimarin, a potent antilipogenic flavonoid, decreases fat deposition in mice intra-abdominal adipose tissue. Int J Obes (Lond). 2010 Nov;34(11):1566‐1575.

88.

Yan

. Acacetin as a potential protective compound against cardiovascular diseases. Evid Based Complement Alternat Med. 2022 Mar 2;2022(1):6265198.

89.

Jiang

Sun

Miao

, et al. The natural flavone acacetin protects against high-fat diet-induced lipid accumulation in the liver via the endoplasmic reticulum stress/ferroptosis pathway. Biochem Biophys Res Commun. 2023 Jan 15;640:183‐191.

90.

Zhang

Dong

, et al. Acacetin exerts antitumor effects on gastric cancer by targeting EGFR. Front Pharmacol. 2023 May 17;14:21643.

91.

Cho

Park

Bae

. Therapeutic effects of (+)-Afzelechin on particulate matter-induced pulmonary injury. Biomol Ther (Seoul). 2024 Jan 1;32(1):162‐169.

92.

Gao

Zhang

Dong

, et al. Traumatic acid inhibits ACSL4 associated lipid accumulation in adipocytes to attenuate high-fat diet-induced obesity. FASEB J. 2023 Dec;37(12):e23278.

93.

Jin

Yang

Cao

, et al. The gut metabolite 3-hydroxyphenylacetic acid rejuvenates spermatogenic dysfunction in aged mice through GPX4-mediated ferroptosis. Microbiome. 2023 Sep 27;11(1):212.

94.

Lee

Moon

Lee

, et al. Swertiajaponin inhibits skin pigmentation by dual mechanisms to suppress tyrosinase. Oncotarget. 2017 Sep 15;8(56):95530‐95541.

95.

Jiang

Peng

Wang

, et al. Cirsiliol regulates mitophagy in colon cancer cells via STAT3 signaling. Cancer Cell Int. 2022 Oct 7;22(1):304.

96.

Nafees

Zafaryab

Mehdi

, et al. Anti-Cancer effect of gingerol in cancer prevention and treatment. Anticancer Agents Med Chem. 2021;21(4):428‐432.

97.

Tong

Qing

Shu

, et al. Deltonin, a steroidal saponin, inhibits colon cancer cell growth in vitro and tumor growth in vivo via induction of apoptosis and antiangiogenesis. Cell Physiol Biochem. 2011;27(3-4):233‐242.

98.

Yang

Liu

Guo

. Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin via inhibiting PI3 K/AKT/mTOR and MAPK signaling. World J Gastrointest Oncol. 2023 Oct 15;15(10):1739‐1755.

99.

Chen

Gao

, et al. Astragaloside III enhances anti-tumor response of NK cells by elevating NKG2D and IFN-γ. Front Pharmacol. 2019 Aug 13;10(10):898.

100.

Wang

Yuan

Cao

, et al. Astragaloside III activates TACE/ADAM17-dependent anti-inflammatory and growth factor signaling in endothelial cells in a p38-dependent fashion. Phytother Res. 2020 May;34(5):1096‐1107.

101.

Zhang

Gao

, et al. Astragaloside IV derived from Astragalus membranaceus: a research review on the pharmacological effects. Adv Pharmacol. 2020;87:89‐112.

102.

Naji Reyhani Garmroudi

Karimi

Oskoueian

, et al. Ferutinin: a phytoestrogen from ferula and its anticancer, antioxidant, and toxicity properties. J Biochem Mol Toxicol. 2021 Apr;35(4):e22713.

103.

Hou

Han

Fei

, et al. Dietary Flavone Tectochrysin Exerts Anti-Inflammatory Action by Directly Inhibiting MEK1/2 in LPS-Primed Macrophages. Mol Nutr Food Res. 2018 Jan;62(2):1-44.

104.

Yan

, et al. Tectochrysin from Alpinia Oxyphylla Miq. Nurses ates Aβ1-42 induced learning and memory deficits in mice. Eur J Pharmacol. 2019 Jan 5;842:365‐372.

105.

Yang

Liu

. Z-Ligustilide ameliorates diabetic rat retinal dysfunction through anti-apoptosis and an antioxidation pathway. Med Sci Monit. 2020 Oct 4;26:e925087.

106.

Liu

Zhu

Zhang

, et al. Isoliquiritigenin ameliorates acute pancreatitis in mice via inhibition of oxidative stress and modulation of the Nrf2/HO-1 pathway. Oxid Med Cell Longev. 2018 Apr 26;2018(1):7161592.

107.

Wang

Jia

Zhang

, et al. Isoliquiritigenin inhibits virus replication and virus-mediated inflammation via NRF2 signaling. Phytomedicine. 2023 Jun;114:154786.

108.

Tang

Luo

Xiao

, et al. Isoliquiritigenin attenuates septic acute kidney injury by regulating ferritinophagy-mediated ferroptosis. Ren Fail. 2021 Dec;43(1):1551‐1560.

109.

Huang

Wang

Xie

, et al. Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice. Phytomedicine. 2022 Jul;101:154117.

110.

Zheng

Xiao

Wang

, et al. Inhibitory effects of ginsenoside ro on the growth of B16F10 melanoma via its metabolites. Molecules. 2019 Aug 17;24(16):2985.

111.

Jiang

Zhuang

, et al. Ginsenoside ro ameliorates high-fat diet-induced obesity and insulin resistance in mice via activation of the G protein-coupled bile acid receptor 5 pathway. J Pharmacol Exp Ther. 2021 Jun;377(3):441‐451.

112.

Zhi

Song

Feng

. Soyasapogenol B attenuates laryngeal carcinoma progression through inducing apoptotic and autophagic cell death. Anat Rec (Hoboken). 2020 Jul;303(7):1851‐1858. doi: https://doi.org/10.1002/ar.24274. Epub 2019 Oct 18. Retraction in: Anat Rec (Hoboken).2021 Dec; 304(12):2902.

113.

Wang

Zhao

, et al. Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma. Naunyn Schmiedebergs Arch Pharmacol. 2019 May;392(5):551‐563. doi: https://doi.org/10.1007/s00210-018-01607-w. Epub 2019 Jan 4. Retraction in: Naunyn Schmiedebergs Arch Pharmacol. 2021 Mar; 394(3):569.

114.

Iqbal

Rizvi

SMD

Rehman

, et al. Soyasapogenol-B as a potential multitarget therapeutic agent for neurodegenerative disorders: molecular docking and dynamics study. Entropy (Basel). 2022 Apr 23;24(5):593.

115.

Liu

Yang

Zhang

, et al. Dendrobium officinale polysaccharide ameliorates diabetic hepatic glucose metabolism via glucagon-mediated signaling pathways and modifying liver-glycogen structure. J Ethnopharmacol. 2020 Feb 10;248:112308.

116.

, et al. Recent advances in polysaccharides from Chaenomeles speciosa (sweet) Nakai.: extraction, purification, structural characteristics, health benefits, and applications. Molecules. 2024 Jun 23;29(13):2984.

117.

Wei

Lai

. Evaluation of the activity of different polar parts and analysis of the isolation and identification of effective constituents in fentail fern. Shanxi Chemical Industry. 2023;43(09):3‐4+17.

118.

Ying

Pan

Wang

, et al. Physicochemical properties, in vitro antioxidant activities and protective effects of liubao tea polysaccharides on HUVEC. Journal of Tea Science. 2017;37(01):25‐37.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.04 MB